A: Axial-section CT of the tempo ral bone in a 43-year-old black woman reveals the soft-tissue mass and bony spicules that are characteristic ofa hemangioma . The mass involves the area ofthe geniculate ganglion of the fa cial nerve and extends into the anterior portion of the tympan ic cavity (arrows). B: Contra st-enhanced axial-s ection MRI at the same level shown inA shows the enhancing mass with multiple pun ctate areas of low intensity, corresponding to the bony spicules (arrows) .
Bell's palsy accounts for almost 50% of all case s of facial nerve paralysis.1 Tumors are involved in only 5% of cases of facial paralysis, and the most common tumors are acoustic and facial neuromas.' Facial nerve hemangiomas account for only 0.7% of all temporal bone tumors .' ? Fac ial nerve hem angiomas arise from vascular plexu ses distributed along the facia l nerve paths in the geniculate ganglion region, in the mastoid segment of the facia l nerve near the origin of the chorda tympani, and in the internal auditory canal around Scarpa's ganglion,"
Microscopically, facial nerve hem angiomas are seen as large vascular spaces lined with thin endothelium surrounded by thick walls filled with uniform fibrous tis-sue.P The characteristic honeycomb appearance seen on computed tomography (CT) ( figure, A) is the result of erosion of the temporal bone and calcification of the collagen-cont aining wall s between the vascular channels. The presence of bony channels, indistinct tumor margins, and intratumor bony spicu les led to the term ossifying hemangiomas ?
High-resolution CT and enhanced magn etic resonance imaging (MRI) (figure, B) nerve dysfunction is seen in patient s with small hemangiomas; tinnitus and dizziness are seldom present. Conversely, symptomatic facial nerve neuromas are relatively large. Facial nerve hemangiomas and neuromas can be differenti ated by their histologic appearance and by the presence or absence of the ossifying characteristics of facial nerve hemangiom as.' Facial nerve hem angiom as should also be distinguished from menin giom as, congenital cholesteatomas, metastatic carcinomas, and other vascular tumor s that involve the temporal bone.
Surgic al removal is the definiti ve treatment. In view of the extrinsic growth pattern of these tumor s, surgical remov al should be performed early to preserve facial nerve function .' Tumors in the geniculate ganglion region usually lead to an intense perineural reaction or direct nerve infiltration .Therefore, the opportun ities to preserve an intact nerve followin g surgery are limited. Treatment by total excision and facial nerve graft ing can provide a perm anent cure and restore facial function.P
